Healthcare provider profile · identity verified

Russell B Harrison, MD

Family Practice · PENDLETON, OR · NPI 1164409173

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	371	92
Levothyroxine Sodium	Levothyroxine Sodium	292	74
Losartan Potassium	Losartan Potassium	205	51
Metoprolol Succinate	Metoprolol Succinate	195	53
Lisinopril	Lisinopril	179	51
Simvastatin	Simvastatin	168	38
Gabapentin	Gabapentin	166	38
Amlodipine Besylate	Amlodipine Besylate	149	37
Omeprazole	Omeprazole	148	37
Potassium Chloride	Potassium Chloride	144	32
Furosemide	Furosemide	135	32
Hydrochlorothiazide	Hydrochlorothiazide	124	32
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	123	23
Sertraline Hcl	Sertraline Hcl	97	21
Metformin Hcl	Metformin Hcl	95	33
Metformin Hcl Er	Metformin Hcl	95	27
Eliquis	Apixaban	86	17
Tamsulosin Hcl	Tamsulosin Hcl	85	27
Pantoprazole Sodium	Pantoprazole Sodium	84	19
Duloxetine Hcl	Duloxetine Hcl	76	17
Glipizide Er	Glipizide	73	23
Meloxicam	Meloxicam	73	12
Acetaminophen-Codeine	Acetaminophen With Codeine	72	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	72	22
Carvedilol	Carvedilol	71	19
Metoprolol Tartrate	Metoprolol Tartrate	71	20
Atenolol	Atenolol	69	18
Allopurinol	Allopurinol	66	16
Amitriptyline Hcl	Amitriptyline Hcl	63	11
Fluoxetine Hcl	Fluoxetine Hcl	62	19
Ozempic	Semaglutide	62	13
Citalopram Hbr	Citalopram Hydrobromide	61	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	14
Tramadol Hcl	Tramadol Hcl	57	15
Fluticasone Propionate	Fluticasone Propionate	53	15
Ropinirole Hcl	Ropinirole Hcl	51	12
Albuterol Sulfate Hfa	Albuterol Sulfate	49	19
Warfarin Sodium	Warfarin Sodium	48	14
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	47	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	47	11
Montelukast Sodium	Montelukast Sodium	46	15
Lovastatin	Lovastatin	44	suppressed
Xarelto	Rivaroxaban	43	suppressed
Clopidogrel	Clopidogrel Bisulfate	42	11
Jardiance	Empagliflozin	41	12
Pravastatin Sodium	Pravastatin Sodium	38	12
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	37	suppressed
Propranolol Hcl	Propranolol Hcl	37	suppressed
Celecoxib	Celecoxib	36	suppressed
Diclofenac Sodium	Diclofenac Sodium	36	suppressed
Irbesartan	Irbesartan	36	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	36	suppressed
Cefdinir	Cefdinir	34	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	34	25
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	11
Prednisone	Prednisone	34	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	33	13
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Finasteride	Finasteride	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Telmisartan	Telmisartan	28	suppressed
Spironolactone	Spironolactone	27	suppressed
Baclofen	Baclofen	26	suppressed
Cephalexin	Cephalexin	26	20
Alprazolam	Alprazolam	24	suppressed
Bupropion Hcl Sr	Bupropion Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Trazodone Hcl	Trazodone Hcl	24	suppressed
Azithromycin	Azithromycin	23	22
Chlorthalidone	Chlorthalidone	23	suppressed
Ondansetron Odt	Ondansetron	23	suppressed
Paroxetine Hcl	Paroxetine Hcl	23	suppressed
Torsemide	Torsemide	23	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	20	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Topiramate	Topiramate	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	19	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Ventolin Hfa	Albuterol Sulfate	18	suppressed
Glipizide	Glipizide	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Amoxicillin	Amoxicillin	16	15
Fluconazole	Fluconazole	16	suppressed
Dilt-Xr	Diltiazem Hcl	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Aspirin-Dipyridamole Er	Aspirin/Dipyridamole	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Prevalite	Cholestyramine	14	suppressed
Azelastine Hcl	Azelastine Hcl	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Diltiazem 24hr Er (Xr)	Diltiazem Hcl	12	suppressed
Famotidine	Famotidine	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Guanfacine Hcl	Guanfacine Hcl	11	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	11	suppressed
Tafluprost	Tafluprost/Pf	11	suppressed
Tiotropium Bromide	Tiotropium Bromide	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Tretinoin	Tretinoin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error